Means for the inhibition of anti-beta1adrenergic receptor antibodies

Details for Australian Patent Application No. 2006228664 (hide)

Owner Julius-Maximilians-Universitat Wurzburg

Inventors Palm, Dieter; Lohse, Martin J.; Jahns, Valerie; Jahns, Roland

Agent Pizzeys

Pub. Number AU-B-2006228664

PCT Pub. Number WO2006/103101

Priority 05007056.4 31.03.05 EP

Filing date 31 March 2006

Wipo publication date 5 October 2006

Acceptance publication date 1 November 2012

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 38/12 Medicinal preparations containing peptides - Cyclic peptides

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 9/04 Drugs for disorders of the cardiovascular system

C07K 7/08 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/64 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/103101 Priority application(s): WO2006/103101

1 November 2012 Application Accepted

  Published as AU-B-2006228664

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228670-Phosphorylated waxy potato starch

2006228663-Antibodies against CCR5 and uses thereof